神经内镜下经鼻中隔黏膜下入路与传统经鼻蝶入路垂体腺瘤切除术的疗效比较

doi:10.3969/j.issn.1671-7171.2024.08.008

Abstract
Figure/Table
References
Related Citation (15)

Download: PDF (1186 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract 【Objective】To compare the clinical outcomes of endoscopic transnasal submucosal approach and traditional transnasal transsphenoidal approach for pituitary adenoma resection. 【Methods】A retrospective analysis was conducted on the clinical data of 85 patients with pituitary adenomas admitted to our hospital from March 2019 to April 2024. According to the surgical approach plan, they were divided into a nasal septum submucosal group (transnasal septum submucosal approach, n=45) and a nasal butterfly group (transnasal butterfly approach, n=40). The incidence of postoperative complications, olfactory function, nasal ventilation function, and hormone levels before and after surgery were compared between the two groups. 【Results】There was no statistically significant difference in the total effective rate between the two groups of patients (P>0.05). The intraoperative tumor resection rate and cerebrospinal fluid leakage rate in the submucosal group of the nasal septum were not significantly different from those in the nasal butterfly group (P>0.05); The operation time and bleeding volume of the submucosal group of the nasal septum were lower than those of the nasal butterfly group, and the difference was statistically significant (P<0.05). Compared with preoperative values, the olfactory recognition thresholds of the two groups were higher at 1 month, 3 months, and 6 months after surgery, and the nasal septum submucosal group was lower than the nasal butterfly group, with statistical significance (P<0.05). At 3 and 6 months after surgery, the nasal inspiratory and expiratory resistance in both groups were higher than before surgery, and the submucosal group of the nasal septum was lower than the nasal butterfly group, with a statistically significant difference (P<0.05). Six months after surgery, the levels of serum prolactin, growth hormone, and adrenocorticotropic hormone in both groups were lower than before surgery (P<0.05), but there was no significant difference in these indicators between the two groups at six months after surgery (P>0.05). The total incidence of postoperative complications in the submucosal group of the nasal septum was lower than that in the nasal butterfly group, and the difference was statistically significant (P<0.05). 【Conclusion】Neuroendoscopic transnasal submucosal approach for pituitary adenoma resection has minimal damage to the patient's olfactory function, low incidence of postoperative complications, and high clinical significance.

Key words： Pituitary Neoplasms/SU Neuroendoscopy Treatment Outcome

Received: 07 June 2024

PACS:

R736.4

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	TAN Bin
	CHEN Ao
	YANG Fan
	et al

Cite this article:

TAN Bin,CHEN Ao,YANG Fan, et al. Comparison of the Therapeutic Effects of Endoscopic Transnasal Submucosal Approach and Traditional Transnasal Transsphenoidal Approach for Pituitary Adenoma Resection[J]. JOURNAL OF CLINICAL RESEARCH, 2024, 41(8): 1144-1147.

URL:

http://journal07.magtech.org.cn/yxlcyj/EN/10.3969/j.issn.1671-7171.2024.08.008 OR http://journal07.magtech.org.cn/yxlcyj/EN/Y2024/V41/I8/1144

[1] 马晓婧,高素敏,柳林.卡麦角林在垂体腺瘤治疗中的临床应用[J].药物生物技术,2022,29(6):657-660.
[2] TRITOS N A, MILLER K K. Diagnosis and management of pituitary adenomas: a review[J].JAMA,2023,329(16):1386.
[3] 张世彬,陈图南,吴国材,等. 神经导航辅助下扩大经鼻蝶入路神经内镜手术切除巨大侵袭性垂体腺瘤1例[J].中国临床神经外科杂志,2023,28(3):219-220.
[4] 中国垂体腺瘤协作组. 中国垂体腺瘤外科治疗专家共识[J].中华医学杂志,2015,95(5):324-329.
[5] CHICOINE M R. Surgery for pituitary adenoma: endoscope versus microscope:Does it make a difference? [J].Mayo Clin Proc,2021,96(8):2020-2021.
[6] 赵嘉辉,陆威成. 垂体腺瘤经鼻蝶入路神经内镜切除术中脑脊液鼻漏的危险因素及修补方法[J].中国临床神经外科杂志,2023,28(12):728-731.
[7] KHAN D Z, HANRAHAN J G, BALDEWEG S E, et al. Current and future advances in surgical therapy for pituitary adenoma[J].Endocr Rev,2023,44(5):947-959.
[8] 孙娴,王培丽,崔圆元. 黏膜下经内镜垂体瘤切除术与传统经鼻内镜垂体瘤切除术对患者围术期指标、嗅觉功能恢复和并发症的影响[J].陕西医学杂志,2023,52(2):192-195.
[9] KUWATA F, KIKUCHI M, ISHIKAWA M, et al. Long-term olfactory function outcomes after pituitary surgery by endoscopic endonasal transsphenoidal approach[J].Auris Nasus Larynx,2020,47(2):227-232.
[10] LI P, LUO K, ZHANG Q H, et al. Superior turbinate management and olfactory outcome after endoscopic endonasal transsphenoidal surgery for pituitary adenoma: a propensity score-matched cohort study[J].Int Forum Allergy Rhinol,2020,10(12):1276.
[11] 姚佳浩.垂体腺瘤经鼻蝶入路神经内镜术后继发嗅觉功能减退的影响因素[J].中国临床神经外科杂志,2023,28(9):591-593.
[12] 马涛,王春琳,胡满苗,等. 鞍底带蒂黏膜骨瓣复位联合带蒂粘膜瓣进行鞍底重建在垂体腺瘤术中的应用[J].中国临床神经外科杂志,2022,27(6):437-439.
[13] 何阳. 神经内镜下经不同入路手术治疗垂体腺瘤的效果及对鼻腔功能的影响[J].中国临床神经外科杂志,2019,24(9):540.